DexCom, Inc.
DXCM
$79.28
-$1.49-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.69% | -6.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.69% | -6.96% | |||
| Cost of Revenue | 4.77% | -2.34% | |||
| Gross Profit | 16.94% | -10.19% | |||
| SG&A Expenses | 5.77% | -5.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.68% | -2.41% | |||
| Operating Income | 59.01% | -29.22% | |||
| Income Before Tax | 56.25% | -26.98% | |||
| Income Tax Expenses | 25.36% | -17.95% | |||
| Earnings from Continuing Operations | 70.59% | -30.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.59% | -30.52% | |||
| EBIT | 59.01% | -29.22% | |||
| EBITDA | 42.28% | -21.48% | |||
| EPS Basic | 70.17% | -30.61% | |||
| Normalized Basic EPS | 55.84% | -27.06% | |||
| EPS Diluted | 68.40% | -30.03% | |||
| Normalized Diluted EPS | 55.98% | -27.10% | |||
| Average Basic Shares Outstanding | 0.26% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||